Navigation Links
Mounting evidence shows health benefits of grape polyphenols
Date:10/28/2008

Philadelphia, PA, October 28, 2008 A growing body of research data suggests that consuming foods rich in polyphenols from grapes, including red wine, helps reduce the risk of heart disease, according to a review article in the November issue of Nutrition Research.

"Consumption of grape and grape extracts and/or grape products such as red wine may be beneficial in preventing the development of chronic degenerative diseases such as cardiovascular disease," write Wayne R. Leifert, Ph.D., and Mahinda Y. Abeywardena, Ph.D., of Commonwealth Scientific and Industrial Research Organisation in Adelaide, Australia.

The authors review the accumulating evidence that grape polyphenols work in many different ways to prevent cardiovascular and other "inflammatory-mediated" diseases. Polyphenols are natural antioxidants found in grapes and some other plant foods. Their types and actions vary, depending on where in the grape they are found. Grape seeds, grape skin, and grape juice contain several types of polyphenols, including resveratrol, phenolic acids, anthocyanins, and flavonoids.

Through their antioxidant effects, grape polyphenols help to slow or prevent cell damage caused by oxidation. Polyphenols decrease oxidation of low-density lipoprotein cholesterol ("bad" cholesterol)a key step in the development of atherosclerosis (hardening of the arteries). Grape polyphenols also have other protective effects on the heart and blood vessels, including actions to reduce blood clotting, abnormal heart rhythms, and blood vessel narrowing. It's not yet clear exactly how these benefits of polyphenols occur, although there is evidence of effects on cellular signaling and on the actions of certain genes. The wide range of health-promoting effects suggests that several different, possibly interrelated mechanisms may be involved.

So far, most of the evidence on grape polyphenols comes from laboratory experiments and animal studies. Ho
'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mounting evidence shows red wine antioxidant kills cancer
2. A private bandwidth for communication in bats: Evidence from insular horseshoe bats
3. Comet probes reveal evidence of origin of life, scientists claim
4. Evidence of a relationship between swimming babies and infections
5. Researchers find evidence linking stress caused by the Sept. 11 disaster with low birth weights
6. Fossil record supports evidence of impending mass extinction
7. New evidence for female control in reproduction
8. RAND study finds evidence disease management programs
9. CWRU School of Medicine has evidence vaccine against malaria will reduce disease
10. There is powerful evidence of evolution in human DNA
11. Scientific evidence supporting evolution continues to grow

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)..., PORTOLA VALLEY, Calif., Oct. 19 ...olecular sensing and imaging devices which shed li...that it has signed exclusive distribution deals fo...nsors. The markets covered include Australia, New...enelux), Suriname, Italy, France, Spain, Portugal,...
(Date:11/4/2009)..., CARLSBAD, Calif., Oct. 23 GenVau...biosample management for genomic discovery, medici...Wellis, Ph.D., GenVault,s President and CEO, will ...king place on October 26th and 27th in La Jolla, C...provide an overview of the company together with r...
(Date:11/4/2009)..., SEATTLE, Nov. 4 Glencoe Software...Environment (OME) Consortium ( http://openmicrosc... with the American Society of Cell Biology,s excit...." The ASCB has been awarded a $2.5M stimulus gran...) Grand Opportunities program, as part of the Amer...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 1Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 2Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 3Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 4Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 52853 5Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 1Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 2Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 1Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 2Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 3Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 4Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 5Mayo Researchers Find Anesthesia Not Harmful for Babies During Birth Process 52850 6
...tive to Irradiation , Researchers led by Dr. Bat...rradiation damages fat tissue. They report their f... Journal of Pathology . , Radiation therapy dir...sues. Autologous transplant of tissues such as fat...s, organ dysfunction, and necrosis that result fro...
...-term gene therapy resulted in improved cardiac fu...rats with heart failure, according to a recent stu...iversity,s Center for Translational Medicine. The ...e rats were treated with a gene that generates a p...d to hearts in combination with recombinant-adeno-...
...RK (DECEMBER 26, 2008) A team of scientists from ...WCS) has reported a rapid recovery of coral reefs ...devastated coastal regions throughout the Indian O...team, working in conjunction with the Australian R...f Studies (ARCCoERS) along with government, commun...
Other Biology News:Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 5Gene therapy reversed heart damage in heart failure 24 years after tsunami: Corals stage comeback 24 years after tsunami: Corals stage comeback 3
(Date:11/5/2009)...eb., Nov. 5 Transgenomic...financial results for the quarter ended September ...ented in the tables that follow. ,, Third Quar... $366,000 or $0.01 per share for the third quarter...$0.01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)... Calif., Nov. 5 WaferGen...ading developer of state-of-the-art genetic analys..., Ph.D. has joined the company,s Scientific Adviso...g and commercializing novel molecular diagnostics ...n the development of computational biology systems...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pr...EB) November 5, 2009 -- Professional Reprographics...ics company is pleased to present Brooke Sanders t...raphics/PR specialist. The addition of Brooke to t...wth within Professional Reprographics., , ,Brooke ...
(Date:11/4/2009)..., ROCKVILLE, Md., Nov. 4 Zyngenia,...cused on next-generation antibody drug development...in Series A funding from New Enterprise Associates... firms. The capital will be used to create novel, ...s two or more biological targets with a single age...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
... Increased Bioavailability, MOUNTAIN VIEW, Calif....e either incurable or difficult to treat allures c...ghly prized, due to their,therapeutic potential, s...riety of diseases. Stem cell research progresses a...em cells have their own unique challenges that,mus...
...LGARY, Oct. 21 /PRNewswire-FirstCall/ - Resverlogi...that the ongoing double blind,placebo controlled P...DL is,progressing as planned. The subjects in the ...afety and tolerability. Thus the safety committee ...t in which 24 subjects will,receive treatment dose...
...rumo Heart, Inc. announced,today that five patient...,Assist System (LVAS), marking an important early ... Dr. Francis Pagani performed the five implants,at...in Ann Arbor with three,of the surgeries performed...ting the first off-pump implants,of DuraHeart in t...
Other Biology Technology:Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan 2Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan 3Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial 2Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial 2
...the submicron range are part of your production or...rol of particle size is important to you. You need...t populations in your sample every time. The N5 Su...tion Spectroscopy (PCS) , which determines particl...
...ndria Derived Activator of Caspase/DIABLO Liquid...THAW CYCLES. Amino acid residues 56 - 239 of human...® sequence was expressed in and purified from...ochrome c during apoptosis and promotes caspase ...
...as originally formulated to support the growth of ...,Antherea eucalypti. The medium is a modification ...hemolymph. The cell lines established by Grace usi...eloped. The basal medium, when properly supplement...
Vsp I from Promega
Biology Products: